Clincosm LogoSign in Get a demo

sclerosis, systemic

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sclerosis, Systemic, Mesenchymal Stem Cells Trial (UCMSC, Placebo)

Recruiting
  • Sclerosis, Systemic
  • Mesenchymal Stem Cells
  • UCMSC
  • Placebo
  • Montreal, Quebec, Canada
    Sir Mortimer B. Davis Jewish General Hospital
Jan 5, 2023

Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in New Orleans (HZN-825)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Sclerosis, Systemic
  • New Orleans, Louisiana
    DelRicht Clinical Research, LLC
Nov 15, 2022

Scleroderma, Systemic, Scleroderma, Diffuse, Sclerosis, Systemic Trial in Adelaide, Fitzroy (FT011, Placebo)

Active, not recruiting
  • Scleroderma, Systemic
  • +2 more
  • Adelaide, South Australia, Australia
  • +1 more
Jul 20, 2022

Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in Worldwide (HZN-825 BID, Placebo, HZN-825 QD)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Sclerosis, Systemic
  • HZN-825 BID
  • +2 more
  • Phoenix, Arizona
  • +48 more
Jun 21, 2022

Prevalence of Hyperprolactinemia in Systemic Scleroderma

Recruiting
  • Sclerosis, Systemic
  • +2 more
  • blood test
  • Lille, France
    Hop Claude Huriez Chu Lille
Oct 4, 2021

Scleroderma, Systemic, Sclerosis, Systemic, Systemic Scleroderma Trial in Worldwide (Pomalidomide (CC-4047), Placebo)

Terminated
Has Results
  • Scleroderma, Systemic
  • +4 more
  • Pomalidomide (CC-4047)
  • Placebo
  • Los Angeles, California
  • +55 more
Oct 16, 2019

Scleroderma, Systemic, Sclerosis, Systemic Trial in London (Interstitial lung disease induction algorithm, Pulmonary arterial

Unknown status
  • Scleroderma, Systemic
  • Sclerosis, Systemic
  • Interstitial lung disease induction algorithm
  • +9 more
  • London, Ontario, Canada
    Saint Joseph's Health Care London
Aug 2, 2018

Sclerosis, Systemic Trial in Worldwide (Placebo, tocilizumab [RoActemra/Actemra])

Completed
Has Results
  • Sclerosis, Systemic
  • Placebo
  • tocilizumab [RoActemra/Actemra]
  • Los Angeles, California
  • +49 more
Aug 2, 2016